Spinal Cord Journal cover

Best articles published on "Spinal Cord" in 2018 – 2019

Spinal Cord, a monthly journal that publishes contributions on spinal cord anatomy, physiology, management of injury and disease, and the quality of life and life circumstances of people with a spinal cord injury, has published a collection of articles from 2018 and…

SpinalCure donates $1.2m to NeuRA to research neurostimulation treatments for spinal cord injury

26 November 2019 SpinalCure Australia (SpinalCure) and Neuroscience Research Australia (NeuRA) are delighted to announce their collaboration to further develop neurostimulation treatments for people with spinal cord injury. Once thought an impossible dream, recent breakthroughs have shown that a cure…

Stakeholders meet with NSW Health officials to discuss $15m funding into SCI research

Stakeholders have met with representatives from the NSW Office for Health and Medical Research to discuss the NSW Government’s $15 million injection in spinal cord injury research. After intense advocacy work by SpinalCure Australia and our supporters, the NSW Government announced the funding…

SCI community 'hopeful' after NSW govt $15m funding announcement

We were honoured to attend to the NSW Treasurer’s Budget speech on Tuesday, and listen to his inspiring words as he announced a $15 million investment into spinal cord injury research.  NSW Treasurer the Hon Dominic Perrottet MP announced  “a new…

NSW to invest $15 million is spinal cord injury research

$15 million to get us closer to the cure We are delighted to share that the NSW Treasurer the Hon Dominic Perrottet MP plans to announce a $15 million investment into spinal cord injury research in Tuesday’s budget. SpinalCure was given the opportunity to present…

Edging toward a breakthrough-Insurance Adviser May 2018

Between 350 and 400 new cases of spinal cord injury are recorded in Australia each year, costing the economy more than $2 billion– inclusive of ongoing care and rehabilitation. Thanks to the pioneering work of Prof Reggie Edgerton, however, those figures…

Asterias provides update for its AST-OPC1 Phase 1/2a Clinical Trial in severe spinal cord injury

Asterias Biotherapeutics, a biotechnology company dedicated to developing cell-based therapeutics, provided an update on how company’s ongoing Phase1/2a SCiStar designed to evaluate the safety and potential efficacy of AST-OPC1 in the treatment of severe cervical spinal cord injury. In the update, Michael…
Racing for Research lunch 2017

Racing for Research lunch raises close to $15,000

We are excited to announce that close to $15,000 was raised from our Inaugural Racing for Research lunch! The event co-hosted by SpinalCure and Spinal Cord Injuries Australia was held on 2nd September at the picturesque grounds of the Royal Randwick…